Hope is on the horizon for children suffering from pneumonia
A drug normally used to prevent tissue rejection following organ transplants could be repurposed to help treat human metapneumovirus (HMPV) infection in children.
A drug normally used to prevent tissue rejection following organ transplants could be repurposed to help treat human metapneumovirus (HMPV) infection in children.
Griffith University research has found that sugars decorating human cells allow toxins, produced by disease-causing bacteria, to bind to human cells and cause damage or death.
Griffith University’s bid to fight the childhood killer pneumonia has received a significant boost following the award of a $304,000 grant from the Bill & Melinda Gates Foundation.
Advancing the fight against pneumonia is the focus of a new online scholarly journal launched by Griffith University ePress.
Institute for Glycomics researchers awarded $1.1 million from NHMRC to develop new antibiotics for drug resistant gonorrhoea.
A class of metal-based compounds acts as a shield to protect cells from viruses new research has found.
An experimental Alzheimer's disease treatment is proving effective at treating some of the most persistent, life-threatening antibiotic-resistant bacteria.
The Institute for Glycomics has been awarded two National Health and Medical Research Council Investigator Grants.
The COVID 19 pandemic is wreaking havoc across the globe. Every segment of most societies will be profoundly impacted. The...
How highly pathogenic influenza viruses such as deadly bird fluinfecthumans is being unravelled.